Of these, 20 patients (54%), all male, with a median age of 73 years (IQR 67–77), were diagnosed with VEXAS syndrome based on the identification of UBA1 mutations through next-generation sequencing (NGS). Here, UBA1 is linked to VEXAS syndrome.